Cancer Health Forums

Cancer Health Main Forums => Cancer Research News & Studies => Topic started by: Cancer Health Editors on June 26, 2018, 11:50:09 am

Title: Immunotherapy Benefits Patients With Advanced Merkel Cell Carcinoma
Post by: Cancer Health Editors on June 26, 2018, 11:50:09 am
Before 2016, patients with advanced Merkel cell carcinoma — a rare and extremely deadly skin cancer — had no good treatment options to extend their lives more than a few months. Then, with two pivotal trials, everything changed.

On June 4, investigators presented new, long-term data from these trials that show immunotherapy drugs help a significant subset of patients with this cancer survive much longer than would otherwise be possible. These results crystalize preliminary results from 2016 and 2017 that were promising enough to change the standard of care for MCC and gain a drug approval from the U.S. Food and Drug Administration, the cancer’s first.

Read more...
https://www.cancerhealth.com/article/immunotherapy-benefits-patients-advanced-merkel-cell-carcinoma (https://www.cancerhealth.com/article/immunotherapy-benefits-patients-advanced-merkel-cell-carcinoma)